| PubMed |
Abstract |
RScore(About this table) |
| 2054651 |
Yamada K, Saltarelli MD, Coyle JT: Effects of calmodulin antagonists on sodium-dependent high-affinity choline uptake. Brain Res. 1991 Feb 22;542(1):132-4.
The effects of calmodulin (CaM) antagonists were investigated on the sodium-dependent high-affinity choline uptake (SDHACU) as assessed by the specific binding of [3H] hemicholinium-3 ([3H] HCh-3) and high-affinity [3H] choline uptake. |
32(0,1,1,2) |
Details |
| 7543649 |
Barron S, Tusell JM, Serratosa J: Effect of hexachlorocyclohexane isomers on calmodulin mRNA expression in the central nervous system. Brain Res Mol Brain Res. 1995 Jun;30(2):279-86.
|
5(0,0,0,5) |
Details |
| 7694769 |
Tusell JM, Barron S, Serratosa J: Anticonvulsant activity of delta-HCH, calcium channel blockers and calmodulin antagonists in seizures induced by lindane and other convulsant drugs. Brain Res. 1993 Sep 17;622(1-2):99-104.
|
2(0,0,0,2) |
Details |
| 7680676 |
Meera P, Tripathi O, Kamboj KK, Rao PR: Role of calcium in biphasic immunomodulation by gamma-HCH (lindane) in mice. Immunopharmacol Immunotoxicol. 1993 Jan;15(1):113-29.
Lymphocyte proliferation was inhibited during both the phases of immune response by verapamil, a calcium channel blocker, and by trifluoperazine, a calmodulin inhibitor. |
1(0,0,0,1) |
Details |